2017-06-26T08:14:51-05:00 2016-12-31 411431363 BERGANKDV LTD 2710 N DODGE ST STE1 IOWA CITY IA 52245 990 2016-01-01 205239366 JOHN PAUL II MEDICAL RESEARCH INSTITUTE JOHN 3196887367 540 E JEFFERSON ST NO 202 IOWA CITY IA 52245 JAY KAMATH PRESIDENT 3196887367 2017-06-14 1 BRUCE GUITHER P00069444 3193543000 69.63.16.145 2017-06-14 10:46:12 CD P 01A9FEF7FDC56B66CCE47A8D864FCEB8E279D27C 2A607E0DA4FE74846D7021B685AA4E0E0FEA5980 2016 2021-01-29 14:40:06Z JAY KAMATH 619 WOODSIDE DR IOWA CITY IA 52246 244783 0 X WWW.JP2MRI.ORG X 2006 IA TO DEVELOP PRECLINICAL RESEARCH TECHNOLOGIES EXCLUSIVELY USING ADULT STEM CELLS AND IPS CELLS THAT WILL ADVANCE DRUG DISCOVERY AND REGENERATIVE MEDICINE. AND TO EDUCATE SCIENTISTS AND THE NEXT GENERATION OF SCIENTISTS IN PRO-LIFE BIOETHICS. 8 6 7 0 0 0 253759 243185 3900 0 -14 -78 0 0 257645 243107 0 0 0 0 345972 139182 5181 2074 20730 338093 186695 689246 327951 -431601 -84844 193350 165583 64428 121505 128922 44078 X TO DEVELOP PRECLINICAL RESEARCH TECHNOLOGIES EXCLUSIVELY USING ADULT STEM CELLS AND IPS CELLS THAT WILL ADVANCE DRUG DISCOVERY AND REGENERATIVE MEDICINE. AND TO EDUCATE SCIENTISTS AND THE NEXT GENERATION OF SCIENTISTS IN PRO-LIFE BIOETHICS. 0 0 226735 TO DEVELOP A COLLABORATIVE BASIC AND CLINICAL RESEARCH PROGRAM IN OUR FOUR CORE RESEARCH AREAS: CANCER, NEURODEGENERATIVE DISEASES, RARE DISEASES, AND ADULT STEM CELL THERAPIES. 226735 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 7 0 0 0 0 0 0 0 0 0 X 8 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 0 0 0 0 X BRIAN DEANE 3196887367 540 E JEFFERSON ST NO 202 IOWA CITY IA 52245 ALAN MOY VICE PRESIDENT 5.00 X 0 0 0 JEANNE MOY DIRECTOR 1.00 X 0 0 0 BISHOP MARTIN AMOS DIRECTOR 1.00 X 0 0 0 ISAAC DOUCETTE DIRECTOR 1.00 X 0 0 0 RAYMOND FLYNN DIRECTOR 1.00 X 0 0 0 JAY KAMATH PRESIDENT 5.00 X 39996 0 0 JANINE IDZIAK SECRETARY 1.00 X 0 0 0 BRIAN DEANE TREASURER 1.50 X 2250 0 0 42246 0 0 0 0 0 0 0 243185 243185 48 48 1550 1676 -126 -126 -126 243107 -126 0 48 42246 42246 79367 68717 10650 7537 7537 10032 5668 3485 879 135 135 7147 7147 2074 2074 4528 4528 10356 7757 2599 1402 1402 8485 8485 36292 36292 807 807 RESEARCH & DEVELOPMENT 75205 75205 RENT - LAB SPACE 39426 39426 MISCELLANEOUS 2887 2887 DONATIONS 25 25 327951 226735 80486 20730 73021 80095 996 661 15188 16974 138566 70713 104145 67853 193350 165583 50460 116027 13968 5478 64428 121505 X 0 0 0 0 128922 44078 128922 44078 193350 165583 -84844 0 X 0 0 0 X 114198 172647 847016 253759 243185 1630805 114198 172647 847016 253759 243185 1630805 77657 1553148 29 25 296 14 48 412 3900 3900 1635117 0.94990 0.93390 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 138566 70713 67853 67853 CREDIT CARD 728 CREDIT CARD 3247 PAYROLL LIABILITIES 1503 5478 FORM 990, PART III, LINE 4A UTILIZATION OF FUNDS FOR 2016: RESEARCH & DEVELOPMENT -- 69% ADMINISTRATIVE -- 25% FUNDRAISING -- 6% FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE 990 WAS DISTRIBUTED TO MEMBERS OF THE GOVERNING BODY BEFORE FILING, AND MEMBERS WERE INSTRUCTED TO REVIEW THE FORM AND PROVIDE FEEDBACK, IF ANY. FORM 990, PART VI, SECTION B, LINE 12C BOARD MEMBERS ARE REQUIRED TO SUBMIT ANNUAL SURVEYS DISCLOSING ANY CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.